- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Human Immunodeficiency Viruses in Germany
Total 1111 results
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus Type 1Germany
-
AbbottCompletedHuman Immunodeficiency Virus-InfectionGermany
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusSpain, France, Germany
-
Johann Wolfgang Goethe University HospitalCompletedHuman Immunodeficiency VirusGermany
-
AlexionAchillion, a wholly owned subsidiary of AlexionCompletedHuman Immunodeficiency Virus (HIV)-1 InfectionUnited States, Spain, Germany, Dominican Republic
-
Janssen-Cilag International NVCompletedHuman Immunodeficiency Virus (HIV) Infections | Acquired Immunodeficiency Syndrome (AIDS) VirusFrance, United Kingdom, Belgium, Germany, Spain, Switzerland, Denmark, Israel, Austria, Poland, Hungary, Sweden, Ireland
-
AbbVie (prior sponsor, Abbott)Completed
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusGermany
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, Peru, Romania, Colombia, South Africa, Germany, Russian Federation, Argentina, Mexico
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus Type 1United States, France, United Kingdom, China, Germany, South Africa, Russian Federation, Argentina, Brazil, Puerto Rico, Austria, Thailand, Mexico, Uganda
-
Clara LehmannGerman Federal Ministry of Education and ResearchCompleted
-
ViiV HealthcarePfizerCompletedHuman Immunodeficiency Virus (HIV) InfectionGermany
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus - Type 1United States, France, United Kingdom, Germany, Taiwan, Spain, Argentina, Chile, Malaysia, Panama, Romania, South Africa, Thailand, Brazil, Puerto Rico, Austria, Hungary, Australia, Guatemala
-
ViiV HealthcareJanssen Research and DevelopmentCompletedHuman Immunodeficiency Virus Type 1 (HIV-1)Germany, Spain, United States, Italy, Canada, Argentina, Sweden
-
AbbottCompletedHuman Immunodeficiency Virus InfectionsUnited States, Australia, Belgium, Canada, Czech Republic, France, Germany, Greece, Ireland, Italy, Netherlands, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Switzerland, Taiwan, United Kingdom
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusGermany
-
Janssen Sciences Ireland UCCompletedImmunodeficiency Virus Type 1, HumanUnited States, France, Poland, United Kingdom, Belgium, Germany, Spain, Canada, Russian Federation, Puerto Rico
-
Rockefeller UniversityUniversity Hospital of CologneCompletedHuman Immunodeficiency Virus (HIV)United States, Germany
-
ViiV HealthcarePfizerCompletedHuman Immunodeficiency Virus-1United States, Spain, Germany
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, France, Germany, Italy, Russian Federation
-
Merck Sharp & Dohme LLCCompletedHuman Immunodeficiency Virus (HIV) InfectionUnited States, Germany
-
ViiV HealthcareGlaxoSmithKline; Janssen PharmaceuticalsCompletedHIV Infections | Infection, Human Immunodeficiency VirusGermany, Spain, France, United States, Canada
-
Rockefeller UniversityAarhus University Hospital; University Hospital of CologneCompletedHuman Immunodeficiency Virus (HIV)Germany, Denmark, United States
-
Janssen-Cilag G.m.b.HCompletedHuman Immunodeficiency Virus (HIV)Germany
-
Janssen-Cilag International NVCompletedHIV Infections | Human Immunodeficiency Virus | Acquired Immunodeficiency Syndrome Virus | AIDS VirusUnited Kingdom, Belgium, Germany, Spain, Portugal, Israel, Denmark, Russian Federation, Austria, Hungary, Switzerland
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States, France, Germany, Canada, Spain, United Kingdom, Mexico, Italy, Argentina, Chile, South Africa, Poland
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusSpain, France, Germany, United States, Italy, Romania, Russian Federation, Switzerland, Puerto Rico
-
ViiV HealthcareGlaxoSmithKline; PPDCompletedHIV Infections | Infection, Human Immunodeficiency VirusTaiwan, France, Germany, Belgium, United States, Canada, Netherlands, Spain, Korea, Republic of, Italy, Australia, United Kingdom, Russian Federation, Portugal, Argentina, South Africa, Romania, Mexico
-
AbbottCompleted
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency Virus IUnited States, Spain, Germany, Australia, Canada, Belgium, Denmark, Netherlands, United Kingdom, France, Italy, Romania
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency Virus IGermany, Spain, France, Australia, United States, Canada, United Kingdom, Italy, Russian Federation
-
ViiV HealthcareTerminatedHIV Infection | Infection, Human Immunodeficiency Virus IUnited States, France, Canada, Germany, Italy, Belgium, United Kingdom, Portugal, Spain
-
GlaxoSmithKlineCompletedHIV Infection | Infection, Human Immunodeficiency Virus IGermany, Belgium, United Kingdom, Spain, Ireland, Italy, France, Austria, Denmark, Netherlands, Switzerland, Portugal, Latvia
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusFrance, Germany, United States, Canada, Belgium, Austria, Brazil, Italy, Poland
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV-1 Infection | Infection, Human Immunodeficiency Virus IGermany, Spain, France, Belgium, United Kingdom, Italy, Romania, Russian Federation, Switzerland
-
GlaxoSmithKlineCompletedHIV Infection | Infection, Human Immunodeficiency VirusUnited States, Belgium, France, Germany, Spain, Canada, Italy, Portugal, Romania, Austria, Switzerland, Poland, Latvia, Luxembourg
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, Argentina, Spain, Germany, Belgium, Australia, Canada, United Kingdom, Italy, Romania, Taiwan, Russian Federation, Mexico, France, Switzerland, Peru, Poland, Portugal
-
ViiV HealthcareCompletedHIV Infection | Infection, Human Immunodeficiency Virus IUnited States, Spain, Germany, Canada, Belgium, Portugal, Italy, France, United Kingdom
-
Jena University HospitalUniversity of Leipzig; Technische Universität Dresden; University of Magdeburg; University of Rostock and other collaboratorsCompletedHIV Seropositivity | CD4+ T LymphocytopeniaGermany
-
ViiV HealthcareTerminatedHIV-1 Infection | Infection, Human Immunodeficiency Virus IUnited States, France, Germany, Canada, Italy, Australia, Belgium, Portugal, Puerto Rico, Romania, United Kingdom
-
ViiV HealthcareTerminatedHIV Infection | Infection, Human Immunodeficiency Virus IUnited States, Germany, France, Canada, Spain, Italy, Portugal, United Kingdom, Denmark, Netherlands
-
ViiV HealthcareGlaxoSmithKline; Janssen PharmaceuticalsActive, not recruitingHIV Infections | Infection, Human Immunodeficiency VirusGermany, Spain, France, United States, Canada, Australia, Korea, Republic of, Italy, South Africa, Russian Federation, Argentina, Mexico, Sweden
-
Gilead SciencesCompletedChronic Hepatitis C | Human Immunodeficiency VirusFrance, Italy, United Kingdom, Germany, Spain, Australia
-
Gilead SciencesCompletedHepatitis C Infection With HIV Co-InfectionUnited Kingdom, Germany
-
PENTA FoundationMedical Research Council; ANRS, Emerging Infectious DiseasesCompletedAntiretroviral Therapy in HIV-1 Infected ChildrenNetherlands, Germany, United Kingdom, Ireland, Thailand
-
OctapharmaCompletedPrimary ImmunodeficiencyUnited Kingdom, Australia, Germany, Italy
-
Janssen R&D IrelandCompletedHepatitis C Virus Genotype-1United States, France, United Kingdom, Germany, Spain, Portugal, Canada, Puerto Rico
-
University of CologneCompletedHIV Infections | Acquired Immunodeficiency SyndromeGermany
-
PfizerCompletedHuman Immunodeficiency VirusUnited States, Spain, South Africa, Italy, France, Germany
-
Novartis VaccinesCompleted